CTTN and breast carcinoma: Moreover, the overexpression of cortactin (CTTN), present in 11q13.3, was linked to CCND1 amplification in premenopausal breast cancer [35], although it failed to demonstrate a strong prognostic value in patients with breast cancer [36].